Literature DB >> 22183170

Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host.

Taradon Luangtongkum1, Zhangqi Shen, Virginia W Seng, Orhan Sahin, Byeonghwa Jeon, Peng Liu, Qijing Zhang.   

Abstract

Campylobacter jejuni is a major zoonotic pathogen transmitted to humans via the food chain and is prevalent in chickens, a natural reservoir for this pathogenic organism. Due to the importance of macrolide antibiotics in clinical therapy of human campylobacteriosis, development of macrolide resistance in Campylobacter has become a concern for public health. To facilitate the control of macrolide-resistant Campylobacter, it is necessary to understand if macrolide resistance affects the fitness and transmission of Campylobacter in its natural host. In this study we conducted pairwise competitions and comingling experiments in chickens using clonally related and isogenic C. jejuni strains, which are either susceptible or resistant to erythromycin (Ery). In every competition pair, Ery-resistant (Ery(r)) Campylobacter was consistently outcompeted by the Ery-susceptible (Ery(s)) strain. In the comingling experiments, Ery(r) Campylobacter failed to transmit to chickens precolonized by Ery(s) Campylobacter, while isogenic Ery(s) Campylobacter was able to transmit to and establish dominance in chickens precolonized by Ery(r) Campylobacter. The fitness disadvantage was linked to the resistance-conferring mutations in the 23S rRNA. These findings clearly indicate that acquisition of macrolide resistance impairs the fitness and transmission of Campylobacter in chickens, suggesting that the prevalence of macrolide-resistant C. jejuni will likely decrease in the absence of antibiotic selection pressure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183170      PMCID: PMC3294946          DOI: 10.1128/AAC.05516-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.

Authors:  J Björkman; I Nagaev; O G Berg; D Hughes; D I Andersson
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Macrolide resistance in Campylobacter coli of animal origin in Denmark.

Authors:  L B Jensen; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori.

Authors:  B Björkholm; M Sjölund; P G Falk; O G Berg; L Engstrand; D I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  Fitness cost of chromosomal drug resistance-conferring mutations.

Authors:  Peter Sander; Burkhard Springer; Therdsak Prammananan; Antje Sturmfels; Martin Kappler; Michel Pletschette; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus.

Authors:  I Nagaev; J Björkman; D I Andersson; D Hughes
Journal:  Mol Microbiol       Date:  2001-04       Impact factor: 3.501

Review 6.  Campylobacter jejuni Infections: update on emerging issues and trends.

Authors:  B M Allos
Journal:  Clin Infect Dis       Date:  2001-03-28       Impact factor: 9.079

7.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

8.  Resistance to quinolones in Campylobacter jejuni and Campylobacter coli from Danish broilers at farm level.

Authors:  K Pedersen; A Wedderkopp
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

9.  Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice.

Authors:  Pål J Johnsen; Gunnar S Simonsen; Orjan Olsvik; Tore Midtvedt; Arnfinn Sundsfjord
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

10.  Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure.

Authors:  Adrien Michon; Nicolas Allou; Françoise Chau; Isabelle Podglajen; Bruno Fantin; Emmanuelle Cambau
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

View more
  20 in total

1.  Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.

Authors:  Swaine L Chen; Meng Wu; Jeffrey P Henderson; Thomas M Hooton; Michael E Hibbing; Scott J Hultgren; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2013-05-08       Impact factor: 17.956

2.  Emergence of multidrug-resistant Campylobacter species isolates with a horizontally acquired rRNA methylase.

Authors:  Yang Wang; Maojun Zhang; Fengru Deng; Zhangqi Shen; Congming Wu; Jianzhong Zhang; Qijing Zhang; Jianzhong Shen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

4.  Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.

Authors:  Haihong Hao; Zonghui Yuan; Zhangqi Shen; Jing Han; Orhan Sahin; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

5.  Antibacterial Activity of 2-(3',5'-Dibromo-2'-methoxyphenoxy)-3,5- dibromophenol Isolated from Phyllospongia papyracea.

Authors:  Shi Sun; Corene Canning; Kuiwu Wang; Wenjun Zhu; Fei Yang; Yifan Zhang; Kequan Zhou
Journal:  Nat Prod Commun       Date:  2017-04       Impact factor: 0.986

Review 6.  The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms.

Authors:  Hannah Bolinger; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2017-05-31       Impact factor: 4.792

7.  Natural Competence and Horizontal Gene Transfer in Campylobacter.

Authors:  Julia Carolin Golz; Kerstin Stingl
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

8.  Synergistic effects of anti-CmeA and anti-CmeB peptide nucleic acids on sensitizing Campylobacter jejuni to antibiotics.

Authors:  Yang Mu; Zhangqi Shen; Byeonghwa Jeon; Lei Dai; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

9.  Effect of Macrolide and Rifampin Resistance on the Fitness of Rhodococcus equi.

Authors:  Jennifer M Willingham-Lane; Londa J Berghaus; Roy D Berghaus; Kelsey A Hart; Steeve Giguère
Journal:  Appl Environ Microbiol       Date:  2019-03-22       Impact factor: 4.792

10.  Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment.

Authors:  Qingqing Xia; Wayne T Muraoka; Zhangqi Shen; Orhan Sahin; Hongning Wang; Zuowei Wu; Peng Liu; Qijing Zhang
Journal:  BMC Microbiol       Date:  2013-06-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.